About Purposeful
Purposeful is a company based in Athens (Greece) founded in 2000. It operates as a AI-as-a-Service and Professional Services. Purposeful has raised $293.9 thousand across 2 funding rounds from investors including PharOS and Metavallon. Purposeful offers products and services including Drug Repurposing for Rare Diseases and AI-Driven Drug Discovery. Purposeful operates in a competitive market with competitors including Moderna, BridgeBio, Spark Therapeutics, Rhythm Pharmaceuticals and Horizon Therapeutics, among others.
- Headquarter Athens, Greece
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$293.9 K (USD)
in 2 rounds
-
Latest Funding Round
Not available
-
Investors
PharOS
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Purposeful
Purposeful offers a comprehensive portfolio of products and services, including Drug Repurposing for Rare Diseases and AI-Driven Drug Discovery.
Drugs are repurposed to treat rare genetic disorders.
AI is utilized to rediscover drugs for diseases.
Funding Insights of Purposeful
Purposeful has successfully raised a total of $293.9K across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Purposeful
Purposeful has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include PharOS and Metavallon.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
VC firm and startup accelerator
|
Locked | Locked | Locked | |
|
Generic drugs are manufactured and supplied by PharOS.
|
Locked | Locked | Locked |
Investor details for Purposeful
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Purposeful
Investment portfolio details for Purposeful
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Purposeful
Detailed financials for Purposeful
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Purposeful Comparisons
Peer comparison for Purposeful
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Purposeful
Purposeful operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, BridgeBio, Spark Therapeutics, Rhythm Pharmaceuticals and Horizon Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| Locked | Locked | Locked |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| Locked | Locked | Locked |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| Locked | Locked | Locked |
Developer of peptide therapeutics for the treatment of rare genetic deficiencies
|
|
| Locked | Locked | Locked |
Developer of drugs for treating rare and autoimmune diseases
|
|
| Locked | Locked | Locked |
Small molecule drugs for rare diseases are developed.
|
Detailed competitors of Purposeful
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Purposeful
Complete news archive for Purposeful
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Purposeful
Purposeful was founded in 2000 and raised its 1st funding round 18 years after it was founded.
Purposeful is headquartered in Athens, Greece.
Purposeful is a funded company, having raised a total of $293.9K across 2 funding rounds to date.
Purposeful is focused on discovering new treatments and developing pharmaceutical products for rare diseases by repurposing already marketed drugs. The company employs AI-driven approaches to revisit both rare and common diseases, aiming to reverse disease phenotypes. Collaborations with organizations like FRAXA, BIOEMTECH, and Leo Pharma Ltd are maintained to identify and validate drug repurposing candidates across various conditions such as Fragile X Syndrome, Glioblastoma, and dermatology indications. The healthcare sector, particularly rare disease treatment, is the primary area of operation.
Purposeful's top competitors include Moderna, Spark Therapeutics and BridgeBio.
Purposeful offers Drug Repurposing for Rare Diseases and AI-Driven Drug Discovery.
Purposeful has 2 investors. Key investors include PharOS, and Metavallon.